James L Tyree's Net Worth
$21.3 Million
Who is James L Tyree?
James L Tyree has an estimated net worth of $21.3 Million. This is based on reported shares across multiple companies, which include ABBOTT LABORATORIES, ChemoCentryx, Inc., THERAVANCE INC, Assertio Holdings, Inc., GENELUX Corp, and DEPOMED INC.
SEC CIK
James L Tyree's CIK is 0001324991
Past Insider Trading and Trends
2007 was James L Tyree's most active year for acquiring shares with 21 total transactions. James L Tyree's most active month to acquire stocks was the month of April. 2009 was James L Tyree's most active year for disposing of shares, totalling 76 transactions. James L Tyree's most active month to dispose stocks was the month of January. 2009 saw James L Tyree paying a total of $9,096,443.60 for 308,362 shares, this is the most they've acquired in one year. In 2009 James L Tyree cashed out on 321,637 shares for a total of $12,126,617.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABBOTT LABORATORIES (ABT) Snapshot price: $113.86
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.55% | -17.27K |
$48.82 | -$843,059.96 | 132.18K |
Feb 27
| |||
Form 4
| +44.19% | 45.8K |
—
|
—
| 149.44K |
Feb 20
| |||
Form 4
| -7.85% | -8.83K |
$54.41 | -$480,574.04 | 103.64K |
Feb 17
| |||
Form 4/A
| +137.86% | 65.19K |
$50.64 | $2,689,319.36 | 112.48K |
Feb 2
| |||
Form 4
| +20.84% | 9.86K |
$50.48 | -$339,559.26 | 57.14K |
Feb 2
| |||
Form 4
| -61.04% | -74.09K |
$54.75 | -$4,056,300.39 | 47.29K |
Feb 2
| |||
Form 4
| +0.11% | 129 |
$51.30 | -$4,787.79 | 121.38K |
Nov 14
| |||
Form 4
| -0.08% | -97.00 |
$51.59 | -$64,056.63 | 121.25K |
Aug 26 - Aug 27
| |||
Form 4
| +1.76% | 2.1K |
$51.41 | -$61,435.30 | 121.34K |
Jul 9
| |||
Form 4
| +1.50% | 1.76K |
$48.53 | -$62,563.09 | 119.24K |
May 14
| |||
Form 4
| -0.46% | -539.00 |
$52.75 | -$28,432.25 | 117.48K |
May 1
| |||
Form 4
| -7.88% | -10.10K |
$53.04 | -$535,486.28 | 118.02K |
Mar 4
| |||
Form 4
| -11.91% | -17.32K |
$53.37 | -$924,364.48 | 128.11K |
Feb 29 - Mar 3
| |||
Form 4
| +1.33% | 1.91K |
$48.52 | -$49,474.33 | 145.43K |
Feb 25
| |||
Form 4
| +22.97% | 26.81K |
$55.61 | $1,489,305.83 | 143.52K |
Feb 15 - Feb 19
| |||
Form 4
| +10.14% | 10.75K |
$49.58 | $443,953.59 | 116.71K |
Aug 27
| |||
Form 4
| +3.22% | 3.31K |
$46.76 | -$94,749.74 | 105.96K |
Aug 22
| |||
Form 4
| -3.70% | -3.94K |
$53.55 | -$211,254.75 | 102.65K |
Jun 30
| |||
Form 4
| -11.12% | -13.33K |
$51.90 | -$1,083,516.96 | 106.6K |
Jun 1
| |||
Form 4
| -0.45% | -540.00 |
$56.62 | -$30,574.80 | 119.93K |
May 1
| |||
Form 4
| +2.91% | 3.41K |
$46.76 | -$116,610.32 | 120.47K |
Feb 20
| |||
Form 4
| +26.74% | 24.7K |
$52.58 | $1,296,495.95 | 117.06K |
Feb 15 - Feb 20
| |||
Form 4
| +2.17% | 1.96K |
$43.22 | -$31,993.54 | 92.36K |
Aug 15
| |||
Form 4
| -0.35% | -320.00 |
$47.50 | -$15,200.00 | 90.41K |
Jul 26
| |||
Form 4
| -3.00% | -2.81K |
$43.18 | -$121,163.08 | 90.73K |
Jul 1
| |||
Form 4
| -0.57% | -540.00 |
$42.70 | -$23,058.15 | 93.53K |
May 1
| |||
Form 4
| +37.25% | 25.53K |
$44.05 | $1,127,665.35 | 94.07K |
Feb 17 - Feb 21
| |||
Form 4
| +2.91% | 1.94K |
$38.03 | -$38,273.77 | 68.54K |
Feb 14
| |||
Form 4
| +26.86% | 14.1K |
$48.66 | $686,106.00 | 66.6K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ChemoCentryx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.14K |
—
|
—
|
0
|
Oct 20
| |||
Form 4
| -52.25% | -10.00K |
$50.22 | -$502,200.00 | 9.14K |
Scheduled
|
Aug 4
| ||
Form 4
| -16.79% | -3.86K |
$25.66 | -$99,129.47 | 19.14K |
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +50.58% | 7.73K |
—
|
—
| 23K |
May 20
| |||
Form 4
|
—
|
0
|
$24.12 | -$817,414.70 | 15.28K |
Scheduled
|
Dec 17
| ||
Form 4
| +16.88% | 2.21K |
$9.76 | -$23,955.95 | 15.28K |
Scheduled
|
May 20 - May 21
| ||
Form 4
| +144.51% | 7.72K |
—
|
—
| 13.07K |
May 21 - May 23
| |||
Form 4
| -84.88% | -30.00K |
$37.06 | -$1,111,686.32 | 5.34K |
Scheduled
|
Jan 13
| ||
Form 4
| +31.28% | 8.42K |
—
|
—
| 35.34K |
May 21 - May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +161.72% | 33.27K |
—
|
—
| 53.85K |
May 25 - May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +43.64% | 6.25K |
$4.39 | -$24,337.05 | 20.57K |
Scheduled
|
May 21 - May 23
| ||
Form 4
|
∞
| 14.32K |
$7.45 | -$94,592.89 | 14.32K |
Scheduled
|
May 21 - May 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THERAVANCE INC (INVA) Snapshot price: $18.7201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.17% | 19.86K |
—
|
—
| 70.55K |
Apr 20
| |||
Form 4
| -1.58% | -813.00 |
$10.47 | -$8,512.11 | 50.7K |
Scheduled
|
May 18
| ||
Form 4
| +51.45% | 18.33K |
—
|
—
| 53.95K |
Apr 26
| |||
Form 4
| -6.84% | -2.44K |
$16.85 | -$41,080.30 | 33.18K |
Scheduled
|
Jun 2
| ||
Form 4
| +64.37% | 13.95K |
—
|
—
| 35.62K |
Apr 24
| |||
Form 4
| +42.85% | 6.5K |
—
|
—
| 21.67K |
Dec 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
∞
| 15.17K |
—
|
—
| 15.17K |
Jun 2
| |||
Form 4
|
∞
| 12K |
—
|
—
| 12K |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Assertio Holdings, Inc. (ASRT) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.16% | -10.25K |
$1.12 | -$11,462.67 | 188.25K |
Mar 14
| |||
Form 4
| +18.64% | 31.19K |
—
|
—
| 198.5K |
May 10
| |||
Form 4
| -20.50% | -43.14K |
$6.00 | -$258,767.40 | 167.31K |
May 5
| |||
Form 4
| -17.50% | -44.64K |
$2.36 | -$105,169.98 | 210.45K |
Scheduled
|
May 12
| ||
Form 4
| +51.11% | 86.29K |
—
|
—
| 255.09K |
May 4
| |||
Form 4
| +112.28% | 357.14K |
—
|
—
| 675.23K |
May 11
| |||
Form 4
| +294.70% | 237.5K |
—
|
—
| 318.09K |
May 19
| |||
| No matching records found | |||||||||
GENELUX Corp (GNLX) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -3.51% | -1.73K |
$2.60 | -$4,498.86 | 47.52K |
Scheduled
|
Sep 11
| ||
Form 4
| +180.64% | 6.25K |
—
|
—
| 9.71K |
May 29
| |||
Form 4
| -72.23% | -9.00K |
$13.22 | -$118,969.02 | 3.46K |
Dec 13
| |||
Form 4
| +38.44% | 3.46K |
—
|
—
| 12.46K |
Sep 11
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||